RBP1 and infection: The absence of optimized assays to characterize functional antibodies against P. vivax, the low frequency of infected individuals and the lack of asymptomatic infections in our population, limited the evaluation of possible associations between anti-PvRMC-RBP1 antibody levels and clinical immunity.